Indication
Type 2 Diabetes
The Type 2 Diabetes pipeline: 131 tracked drugs, 33 approved for this indication.
33 approved / phase 462 Phase 31 Phase 2/315 Phase 21 Phase 1/212 Phase 17 preclinical / unstaged
Compare the share prices of listed companies in Type 2 Diabetes →
Total attributable cost
$324.6B
$12,022/patient
Drug spend
$126.1B
$4,670/patient
39% of total cost is drugs
All severities · US